Log in to save to my catalogue

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6403fda9ca74d4599cc113bbc9a49d9

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

About this item

Full title

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Publisher

London: Nature Publishing Group UK

Journal title

npj vaccines, 2022-10, Vol.7 (1), p.118-118, Article 118

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Using our strongly immunogenic SmT1 SARS-CoV-2 spike antigen platform, we developed antigens based on the Beta & Delta variants of concern (VOC). These antigens elicited higher neutralizing antibody activity to the corresponding variant than comparable vaccine formulations based on the original reference strain, while a multivalent vaccine generate...

Alternative Titles

Full title

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d6403fda9ca74d4599cc113bbc9a49d9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d6403fda9ca74d4599cc113bbc9a49d9

Other Identifiers

ISSN

2059-0105

E-ISSN

2059-0105

DOI

10.1038/s41541-022-00540-7

How to access this item